Literature DB >> 3753539

Murine type II collagen arthritis. Association of an acute-phase response with clinical course.

M L Bliven, P H Wooley, M B Pepys, I G Otterness.   

Abstract

The acute-phase reactant, C-reactive protein, is a good index of disease activity in patients with rheumatoid arthritis. We examined the murine acute-phase reactant, serum amyloid P, as an index of disease in type II collagen-induced arthritis in 3 mouse strains. The onset of type II collagen-induced arthritis, which is characterized by paw swelling, is associated with a significant, but transient, elevation of serum amyloid P. Anticollagen antibody titers are not temporally associated with the onset of disease. Although murine type II collagen arthritis fails to show the chronic acute-phase reactant elevation that is characteristic of arthritis in humans, the transient elevation of the acute-phase reactant is a reliable indicator of the onset of disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3753539     DOI: 10.1002/art.1780290911

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  4 in total

1.  Influence of long term silicone implantation on type II collagen induced arthritis in mice.

Authors:  C J Schaefer; W D Lawrence; P H Wooley
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

2.  Effect of IL-10 on collagen-induced arthritis in mice.

Authors:  Y Tanaka; T Otsuka; T Hotokebuchi; H Miyahara; H Nakashima; S Kuga; Y Nemoto; H Niiro; Y Niho
Journal:  Inflamm Res       Date:  1996-06       Impact factor: 4.575

3.  An anti-inflammatory role for interleukin-11 in established murine collagen-induced arthritis.

Authors:  M Walmsley; D M Butler; L Marinova-Mutafchieva; M Feldmann
Journal:  Immunology       Date:  1998-09       Impact factor: 7.397

4.  Bacterial lipopolysaccharide potentiates type II collagen-induced arthritis in mice.

Authors:  R G Caccese; J L Zimmerman; R P Carlson
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.